Positron emission tomography neuroreceptor imaging as a tool in drug discovery, research and development (Q33695778)

28 July 2017

1 reference

title

Positron emission tomography neuroreceptor imaging as a tool in drug discovery, research and development (English)

1 reference

positron emission tomography

28 July 2017

1 reference

1 reference

Burns HD

1

1 reference

28 July 2017

Hamill TG

2

1 reference

28 July 2017

Eng WS

3

1 reference

28 July 2017

Francis B

4

1 reference

28 July 2017

Fioravanti C

5

1 reference

28 July 2017

Gibson RE

6

1 reference

28 July 2017

language of work or name

1 reference

1 August 1999

1 reference

Current Opinion in Chemical Biology

28 July 2017

published in

1 reference

28 July 2017

volume

3

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

388-394

1 reference

The imaging science of positron emission tomography

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(99)80059-3

7 January 2021

The advantage of using positron emission tomography in drug research

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(99)80059-3

7 January 2021

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(99)80059-3

7 January 2021

Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(99)80059-3

7 January 2021

Positron emission tomography (PET) methodology for small animals and its application in radiopharmaceutical preclinical investigation

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(99)80059-3

7 January 2021

In Vivo Imaging of Neurotransmitter Systems Using Radiolabeled Receptor Ligands

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(99)80059-3

7 January 2021

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(99)80059-3

7 January 2021

Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(99)80059-3

7 January 2021

Imaging dopamine receptors in the human brain by positron tomography

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(99)80059-3

7 January 2021

Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(99)80059-3

7 January 2021

Time Course of 5-HT2A Receptor Occupancy in the Human Brain after a Single Oral Dose of the Putative Antipsychotic Drug MDL 100,907 Measured by Positron Emission Tomography

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(99)80059-3

7 January 2021

The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(99)80059-3

7 January 2021

Radiosynthesis and autoradiographic evaluation of [11C]NAD-299, a radioligand for visualization of the 5-HT1A receptor

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(99)80059-3

7 January 2021

Quantification of Muscarinic Cholinergic Receptors with [11C]NMPB and Positron Emission Tomography: Method Development and Differentiation of Tracer Delivery from Receptor Binding

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(99)80059-3

7 January 2021

10.1016/S1367-5931(99)80059-3

Identifiers

DOI

1 reference

28 July 2017

1 reference